Split history for Simulations Plus Inc
Simulations Plus Inc has split the face value 2 times since Aug. 14, 2006. Simulations Plus Inc had last split the face value of its shares from $2 to $1 in 2007.The share has been quoting on an ex-split basis from Oct. 2, 2007.
| Split Date | Split Ratio |
|---|---|
| 02 Oct 2007 | 2:1 Stock split |
| 14 Aug 2006 | 2:1 Stock split |
Dividend history for Simulations Plus Inc
Simulations Plus Inc has declared 51 dividends since Feb. 16, 2012.
| Ex-Date | Dividend Amount | Instrument Type |
|---|---|---|
| 29 Jul 2024 | 0.06 | Equity Share |
| 26 Apr 2024 | 0.06 | Equity Share |
| 26 Jan 2024 | 0.06 | Equity Share |
| 27 Oct 2023 | 0.06 | Equity Share |
| 28 Jul 2023 | 0.06 | Equity Share |
| 21 Apr 2023 | 0.06 | Equity Share |
| 27 Jan 2023 | 0.06 | Equity Share |
| 28 Oct 2022 | 0.06 | Equity Share |
| 22 Jul 2022 | 0.06 | Equity Share |
| 22 Apr 2022 | 0.06 | Equity Share |
| 28 Jan 2022 | 0.06 | Equity Share |
| 22 Oct 2021 | 0.06 | Equity Share |
| 23 Jul 2021 | 0.06 | Equity Share |
| 23 Apr 2021 | 0.06 | Equity Share |
VIEW MORE
Board Meetings - Simulations Plus Inc
The next board meeting for Simulations Plus Inc is on 03 Apr 2026 for the purpose of Simulations Plus Inc Second Quarter Earnings Results for 2026
| Ex-Date | Purpose | Notes |
|---|---|---|
| 14 Jul 2026 | Simulations Plus Inc Third Quarter Earnings Conference Call for 2026 | - |
| 14 Jul 2026 | Simulations Plus Inc Third Quarter Earnings Results for 2026 | - |
| 02 Jul 2026 | Simulations Plus Inc Third Quarter Earnings Conference Call for 2026 | - |
| 02 Jul 2026 | Simulations Plus Inc Third Quarter Earnings Results for 2026 | - |
| 03 Apr 2026 | Simulations Plus Inc Second Quarter Earnings Conference Call for 2026 | - |
| 03 Apr 2026 | Simulations Plus Inc Second Quarter Earnings Results for 2026 | - |
| 13 Feb 2026 | Simulations Plus Inc Annual General Meeting for 2025 | - |
| 12 Feb 2026 | Simulations Plus Inc Annual General Meeting for 2025 | - |
| 22 Jan 2026 | Clinical Pharmacology Considerations and Modeling of CAR-T Cell Therapies Using Monolix | - |
| 21 Jan 2026 | Virtual Investor Day | - |